Overview

Cost-Effectiveness Study Comparing Chlorhexidine Bathing With Active Surveillance Cultures to Prevent Methicillin-resistant Staphylococcus Aureus & Other Hospital Infections

Status:
Completed
Trial end date:
2009-07-01
Target enrollment:
0
Participant gender:
All
Summary
This pilot study in our medical intensive care unit will evaluate the clinical and cost-effectiveness of an active surveillance program for methicillin-resistant Staphylococcus aureus (MRSA), compared to routine daily bathing with chlorhexidine gluconate (CHG)-impregnated cloths. Outcomes include rate of MRSA acquisition, and of other hospital-acquired infections (e.g., catheter-associated bloodstream infections).
Phase:
N/A
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Christiana Care Health Services
Collaborator:
Sage Products, Inc.
Treatments:
Chlorhexidine
Chlorhexidine gluconate
Methicillin
Criteria
Inclusion Criteria:

- All patients admitted to the medical intensive care unit (ICU) are eligible for
inclusion

Exclusion Criteria:

- Patient refusal

- Contraindication to nasal swabbing (arm 1)

- Allergy/sensitivity to chlorhexidine gluconate (CHG) (arm 2)